Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
mammal (beef, lamb pork) / bee venom (honey bee)
 
Attending: ___.
 
Chief Complaint:
Urinary retention
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ is a ___ yo woman with metastatic recurrence ER/PR
positive HER2negative breast cancer c/b cord compression s/p
laminectomy ___, progressive through doxil (___) s/p 1 dose
taxol, who presents with 1 month of urinary retention with
outpatient sacral MRI showing soft tissue mass around sacral
plexus. 

She recalls first developing symptoms of urinary retention 1
month ago on the date of taxol administration. She presented to
ED at ___ ___. An MRI L spine was done and
reportedly negative for cord pathology. A foley catheter was
placed. She followed up in ___ clinic and passed a voiding
trial ___. Her retention was attributed to constipation from
taxol. Despite this, she had ongoing symptoms of urinary
retention and required replacement of foley catheter ___ at her
PCP ___. An outpatient repeat total spine imaging was pursued
which was unremarkable. However, a sacral MRI was done yesterday
which reportedly showed a pathologic fracture in the sacrum and 
a
soft tissue mass extending into the sacral plexus. She was
referred to ___ for further evaluation. 

In the ED: 98.6 | 91 | 151/58 | 16 | 96% RA. She arrived with
foley catheter in place. Ortho spine was consulted and
recommended obtaining sacral MRI images, but preliminarily felt
that this would not be a surgical issue. 

When seen in at bedside, Ms ___ says she feels in her USOH. 
No
fevers, chills, cold symptoms, cough, chest pain, shortness of
breath, N/V, abdominal pain, back pain, weakness,
numbness/tingling, saddle anesthesia, headache, blurry vision.
She feels a little constipated, last BM was today. 

 
Past Medical History:
- Metastatic breast cancer
- HTN
- HLP
- Diverticulosis
- Osteonecrosis ___ Zometa (last given ___

 
Social History:
She is widowed as of ___. Lives at home in ___ alone. She
had smoked up to 2ppd since high school but quit ___. She is
drinking 4 drinks per day (scotch at bedtime and wine during
day). She does not use illicit drugs. She has her Ph.D. in
chemistry. She retired in ___.
 
Physical Exam:
General: Well appearing talkative older Caucasian woman, sitting
up in bed in no acute distress
Neuro:
- Cranial nerves: PERRL, EOMI, Facial sensation equal
bilaterally, resists eye opening ___, hearing intact to finger
rub b/l, palate elevates symmetrically, tongue midline, shoulder
shrug ___
- Motor: 
___ deltoid, bicep, tricep, handgrip bilaterally
___ hip flexion, knee extension/flexion, plantar and 
dorsiflexion
- Sensation intact to light touch over UE and ___ 
___: MMM, small erythematous lesion in the hard palate
Cardiovascular: RRR no mr
___: CTAB
Abdomen: Soft, nontender, nondistended
Pelvis/GU: Foley catheter in place, draining clear dark yellow
urine
Extr/MSK: No peripheral edema, WWP
Skin: No acute rashes
Access: PIV
 
Brief Hospital Course:
___ with metastatic recurrence ER/PR positive HER2 negative 
breast cancer c/b cord compression s/p laminectomy ___, 
progressive through doxil (___) s/p 1 dose taxol, who 
presents with urinary retention with outpatient sacral MRI 
showing soft tissue mass around sacral plexus. 

# Urinary retention
# Soft tissue sacral mass
Presents with 1 month of urinary retention. Outpatient MRI c/f 
new sacral mass. Her symptoms are stable on admission. 

She was admitted from ED after concerns that sacral MRI images 
could not be obtained for review by orthopedics. On arrival to 
floor, digital images acquired from ___ MRI. Orthopedics 
confirmed she would not benefit from surgical intervention and 
recommended radiation. She will follow up with them in ___ weeks 
and Dr ___ will refer her to radiation at ___, 
where she previously received treatment. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Lisinopril 10 mg PO DAILY 
2. Atenolol 100 mg PO DAILY 
3. Hydrochlorothiazide 12.5 mg PO DAILY 
4. biotin 1,000 mcg oral DAILY 
5. vitamins  A,C,E-zinc-copper 1 capsule oral DAILY 
6. Aspirin 81 mg PO DAILY 
7. Senna 17.2 mg PO BID 
8. Probiotic (B.breve-L.acid-L.rham-S.thermo;<br>L. 
acidophilus-L. rhamnosus;<br>L.rhamn 
A
-
___
-
___ 
40-Bifido 3-S.thermop;<br>Lactobacillus 
acidophilus;<br>lactobacillus comb no.10;<br>lactobacillus 
combination no.4;<br>lactobacillus combo no.11) 1 capsule oral 
DAILY 
9. Vitamin D ___ UNIT PO DAILY 
10. Hydrocortisone (Rectal) 2.5% Cream ___ID:PRN 
hemorrhoids 

 
Discharge Medications:
1.  Aspirin 81 mg PO DAILY  
2.  Atenolol 100 mg PO DAILY  
3.  biotin 1,000 mcg oral DAILY  
4.  Hydrochlorothiazide 12.5 mg PO DAILY  
5.  Hydrocortisone (Rectal) 2.5% Cream ___ID:PRN 
hemorrhoids  
6.  Lisinopril 10 mg PO DAILY  
7.  Probiotic (B.breve-L.acid-L.rham-S.thermo;<br>L. 
acidophilus-L. rhamnosus;<br>L.rhamn 
A
-
___
-
___ 
40-Bifido 3-S.thermop;<br>Lactobacillus 
acidophilus;<br>lactobacillus comb no.10;<br>lactobacillus 
combination no.4;<br>lactobacillus combo no.11) 1 capsule oral 
DAILY  
8.  Senna 17.2 mg PO BID  
9.  Vitamin D ___ UNIT PO DAILY  
10.  vitamins  A,C,E-zinc-copper 1 capsule oral DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Sacral Mass

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
                             ___ MD ___
 
Completed by: ___